Invention Grant
US09511068B2 Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
有权
用于治疗或预防由血管通透性引起的疾病的组合物，其含有伊马替尼或其药学上可接受的盐作为活性成分
- Patent Title: Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
- Patent Title (中): 用于治疗或预防由血管通透性引起的疾病的组合物，其含有伊马替尼或其药学上可接受的盐作为活性成分
-
Application No.: US14409441Application Date: 2013-06-10
-
Publication No.: US09511068B2Publication Date: 2016-12-06
- Inventor: Won Hee Suh , Ji Yeon Kim
- Applicant: AJOU UNIVERSITY INDUSTRY - ACADEMIC COOPERATION FOUNDATION
- Applicant Address: KR Suwon-si, Gyeonggi-do KR
- Assignee: Ajou University Industry-Academic,Cooperation Foundation
- Current Assignee: Ajou University Industry-Academic,Cooperation Foundation
- Current Assignee Address: KR Suwon-si, Gyeonggi-do KR
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: KR10-2012-0065193 20120618
- International Application: PCT/KR2013/005068 WO 20130610
- International Announcement: WO2013/191401 WO 20131227
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D401/04
Abstract:
The present invention relates to a pharmaceutical composition for treating or preventing diseases caused by vascular permeability, containing imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for treating disease caused by vascular permeability using the composition. The pharmaceutical composition for treating or preventing diseases caused by vascular permeability of the present invention contains imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, as an active ingredient, so as to provide a novel use of imatinib and to be able to effectively treat or prevent diseases caused by vascular permeability, and thus may be widely applied to develop a novel agent for treating diseases caused by vascular permeability.
Public/Granted literature
Information query
IPC分类:
